Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | carnitine O-palmitoyltransferase II, putative | 0.0544 | 0.0564 | 0.109 |
Loa Loa (eye worm) | hypothetical protein | 0.3244 | 1 | 1 |
Leishmania major | choline/Carnitine o-acyltransferase-like protein | 0.1864 | 0.5176 | 1 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.1864 | 0.5176 | 1 |
Onchocerca volvulus | 0.0382 | 0 | 0.5 | |
Trypanosoma brucei | carnitine O-palmitoyltransferase II, putative | 0.0544 | 0.0564 | 1 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0544 | 0.0564 | 0.0564 |
Schistosoma mansoni | choline o-acyltransferase | 0.0382 | 0 | 0.5 |
Onchocerca volvulus | 0.0382 | 0 | 0.5 | |
Loa Loa (eye worm) | choline/Carnitine O-acyltransferase | 0.0544 | 0.0564 | 0.0564 |
Schistosoma mansoni | choline o-acyltransferase | 0.0382 | 0 | 0.5 |
Leishmania major | carnitine palmitoyltransferase-like protein | 0.0544 | 0.0564 | 0.109 |
Echinococcus granulosus | carnitine O palmitoyltransferase 2 | 0.0544 | 0.0564 | 0.109 |
Onchocerca volvulus | 0.0382 | 0 | 0.5 | |
Onchocerca volvulus | 0.0382 | 0 | 0.5 | |
Echinococcus multilocularis | carnitine O palmitoyltransferase 1, liver | 0.1864 | 0.5176 | 1 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 2 | 0.0544 | 0.0564 | 0.109 |
Echinococcus granulosus | carnitine O palmitoyltransferase 1 liver | 0.1864 | 0.5176 | 1 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.1864 | 0.5176 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.